Upperton to Attend DCAT Week in New York, 16-19 March
Upperton will attend DCAT Week 2025, Nikki Whitfield, CEO, and Ian Lafferty, CTO, will represent Upperton during the event.
Newsletter
2022: A year of unparalleled growth for Upperton
December 21st 2022 : Newsletter Traditionally at this time of year we like to offer Season’s Greetings to all our customers and friends and whilst doing so, look back over the years at some of the highlights in what has been an exceptionally busy (and successful) year for Upperton Pharma Solutions! Here are just a … Read more
Successful MHRA Inspection & New Capsule Filling Technology
August 16th 2022 : Newsletter Upperton is delighted to announce that during the last week of July 2022 the UK MHRA conducted a routine, three day inspection of the GMP facility and Quality Control testing laboratories following which, no Critical or Major observations were raised. Speaking after the inspection, CEO Nikki Whitfield was quick to … Read more
Upperton Adds New Nasal and Oral Delivery Technologies
January 27th 2022 : Newsletter Upperton is pleased to announce that it has bolstered its nasal and oral delivery capabilities with the addition of a number of new analytical and formulation technologies. Nasal Delivery News – Upperton enhances its analytical capabilities by acquiring next generation nasal particle impaction technology Upperton has acquired the Copley Alberta Idealised … Read more
What’s New In 2022: Exciting Plans For Upperton Pharma Solutions
January 13th 2022 : Newsletter Happy New Year to all of our customers and our friends across the industry! There is no doubt that 2021 was a challenging year for everyone in one way or another, but its fair to say that it was also a year of progress and growth for many in the … Read more
